Market Closed -
Swiss Exchange
11:30:41 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
81
CHF
|
-0.74%
|
|
-0.49%
|
-3.57%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
513.5
|
547.7
|
1,538
|
972.2
|
1,038
|
1,098
|
-
|
-
|
Enterprise Value (EV)
1 |
440.4
|
492.1
|
1,480
|
979.6
|
1,064
|
1,121
|
1,117
|
1,097
|
P/E ratio
|
-
|
-581
x
|
224
x
|
-167
x
|
1,680
x
|
116
x
|
69.5
x
|
47.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.95
x
|
4.39
x
|
9.62
x
|
5.32
x
|
4.9
x
|
4.5
x
|
3.82
x
|
3.24
x
|
EV / Revenue
|
3.38
x
|
3.95
x
|
9.25
x
|
5.36
x
|
5.02
x
|
4.59
x
|
3.89
x
|
3.23
x
|
EV / EBITDA
|
22
x
|
25
x
|
54
x
|
60.5
x
|
31.7
x
|
28
x
|
22.5
x
|
17.7
x
|
EV / FCF
|
-
|
234
x
|
114
x
|
-50.6
x
|
211
x
|
297
x
|
84.6
x
|
-
|
FCF Yield
|
-
|
0.43%
|
0.88%
|
-1.98%
|
0.47%
|
0.34%
|
1.18%
|
-
|
Price to Book
|
2.38
x
|
2.57
x
|
6.87
x
|
4.09
x
|
4.07
x
|
3.67
x
|
3.48
x
|
3.23
x
|
Nbr of stocks (in thousands)
|
11,751
|
11,778
|
11,814
|
11,857
|
12,359
|
13,559
|
-
|
-
|
Reference price
2 |
43.70
|
46.50
|
130.2
|
82.00
|
84.00
|
81.60
|
81.60
|
81.60
|
Announcement Date
|
3/3/20
|
3/10/21
|
3/7/22
|
3/14/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
130.1
|
124.7
|
159.9
|
182.8
|
212
|
244
|
287.4
|
339.1
|
EBITDA
1 |
20
|
19.7
|
27.4
|
16.2
|
33.6
|
40.09
|
49.72
|
61.88
|
EBIT
1 |
7
|
3.8
|
11.06
|
-1.922
|
9.104
|
16.45
|
23.85
|
32.31
|
Operating Margin
|
5.38%
|
3.05%
|
6.92%
|
-1.05%
|
4.29%
|
6.74%
|
8.3%
|
9.53%
|
Earnings before Tax (EBT)
1 |
3.319
|
-3.264
|
8.29
|
-7.145
|
1.794
|
9.504
|
19.21
|
27.5
|
Net income
1 |
2.147
|
-0.9436
|
6.838
|
-5.783
|
0.619
|
8.751
|
14.63
|
21.54
|
Net margin
|
1.65%
|
-0.76%
|
4.28%
|
-3.16%
|
0.29%
|
3.59%
|
5.09%
|
6.35%
|
EPS
2 |
-
|
-0.0800
|
0.5800
|
-0.4900
|
0.0500
|
0.7027
|
1.175
|
1.709
|
Free Cash Flow
1 |
-
|
2.102
|
12.97
|
-19.36
|
5.046
|
3.78
|
13.2
|
-
|
FCF margin
|
-
|
1.69%
|
8.11%
|
-10.59%
|
2.38%
|
1.55%
|
4.59%
|
-
|
FCF Conversion (EBITDA)
|
-
|
10.67%
|
47.34%
|
-
|
15.02%
|
9.43%
|
26.55%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
189.7%
|
-
|
815.19%
|
43.19%
|
90.22%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/3/20
|
3/10/21
|
3/7/22
|
3/14/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 S2
|
2022 S1
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
73.6
|
86.31
|
88.38
|
103.3
|
108.8
|
EBITDA
1 |
14.1
|
13.3
|
9.9
|
13.1
|
18.8
|
EBIT
|
6.3
|
4.798
|
1.3
|
2.8
|
-
|
Operating Margin
|
8.56%
|
5.56%
|
1.47%
|
2.71%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
1.649
|
Net income
1 |
7.1
|
-0.2449
|
0.00377
|
-0.8
|
1.467
|
Net margin
|
9.65%
|
-0.28%
|
0%
|
-0.77%
|
1.35%
|
EPS
|
0.6000
|
-0.0200
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/17/21
|
3/7/22
|
8/16/22
|
8/15/23
|
3/12/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
7.35
|
25.4
|
22.7
|
18.4
|
-
|
Net Cash position
1 |
73.1
|
55.6
|
58.6
|
-
|
-
|
-
|
-
|
1.71
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.4537
x
|
0.7547
x
|
0.5672
x
|
0.3709
x
|
-
|
Free Cash Flow
1 |
-
|
2.1
|
13
|
-19.4
|
5.05
|
3.78
|
13.2
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-0.44%
|
3.13%
|
-
|
0.25%
|
3.72%
|
4.97%
|
7.01%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
18.40
|
18.10
|
19.00
|
20.10
|
20.60
|
22.30
|
23.50
|
25.30
|
Cash Flow per Share
2 |
-
|
1.070
|
1.780
|
-0.3300
|
1.630
|
2.650
|
2.430
|
2.810
|
Capex
1 |
-
|
10.5
|
8.02
|
15.4
|
14.9
|
18.9
|
19.8
|
15.8
|
Capex / Sales
|
-
|
8.43%
|
5.02%
|
8.44%
|
7.04%
|
7.73%
|
6.88%
|
4.66%
|
Announcement Date
|
3/3/20
|
3/10/21
|
3/7/22
|
3/14/23
|
3/12/24
|
-
|
-
|
-
|
Last Close Price
81.6
CHF Average target price
98.98
CHF Spread / Average Target +21.29% Consensus |
1st Jan change
|
Capi.
|
---|
| -3.57% | 1.21B | | +13.16% | 128B | | -8.76% | 10.65B | | +3.60% | 8.82B | | +19.75% | 7.19B | | +22.28% | 4.99B | | +7.55% | 3.4B | | -0.21% | 3.03B | | -4.80% | 2.14B | | -4.72% | 2B |
Medical Devices & Implants
|